Sr Director, Commercial Product Strategy

Gilead SciencesFoster City, CA
Onsite

About The Position

At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers. We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. As a Senior Director – Inflammation , at Gilead you will lead early commercialization strategy for pipeline assets across inflammation and immunology, representing the commercial perspective from pre‑clinical development through early and mid‑stage clinical programs. Reporting to the Vice President, Global Commercial Liver, Inflammation, COVID‑19 and Established Products, this role is accountable for guiding pre‑proof‑of‑concept (pre‑POC) and early commercialization activities to inform development decisions, product profiles, and investment priorities. The role operates in a highly cross‑functional environment and is responsible for integrating market, payer, provider, patient, and competitive insights into development strategy to maximize long‑term patient impact and commercial value.

Requirements

  • Bachelor’s degree and fourteen (14) years of relevant experience or Master’s degree and twelve (12) years of relevant experience or PhD and twelve (12) years of relevant experience

Nice To Haves

  • Experience in inflammation, immunology, liver disease, or related therapeutic areas
  • Demonstrated experience influencing product development decisions through early commercialization strategy
  • Experience evaluating pipeline assets, partnerships, or business development opportunities
  • Knowledge of global value, access, and pricing strategy, including development of value narratives and evidence planning
  • Familiarity with U.S. payer dynamics and global market access considerations
  • Strong ability to build collaborative relationships across Commercial, Medical Affairs, Research, Development, Regulatory, and Value & Access teams
  • Experience operating effectively in global, matrixed organizations

Responsibilities

  • Lead Early Commercialization Teams and partner with Global Asset Teams from pre‑clinical development through initiation of Phase III, ensuring clear transition to inline teams as programs enter late‑stage development
  • Provide commercial input into development strategy, target product profiles, and portfolio prioritization decisions
  • Synthesize commercial insights to support evaluation of business development opportunities, including acquisitions and partnerships
  • Guide teams in developing deep understanding of disease landscapes, unmet need, competitive dynamics, and stakeholder perspectives
  • Partner with Global Value & Access, Commercialization, Medical Affairs, Development, and selected country teams to integrate global and local insights into cohesive strategies
  • Serve as the commercial lead for selected partnered or collaborative pipeline programs
  • Support early commercialization planning activities as appropriate, including foundational branding, positioning, and launch readiness considerations

Benefits

  • company-sponsored medical, dental, vision, and life insurance plans
  • discretionary annual bonus
  • discretionary stock-based long-term incentives
  • paid time off
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service